87P Clinical outcomes of metastasic melanoma patients treated with ipilimumab and nivolumab: A single institution experience

ConclusionIn our cohort, LDH, ECOG and irAEs and no previous treatment were found predictors of response and overall survival. Our median OS and ORR were slighly slower than reported in trials.Legal entity responsible for the studyThe authors.FundingHas not received any funding.DisclosureA.M. Arance Fernandez: Honoraria (self): Bristol-Myers Squibb. All other authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research